Grace Therapeutics (GRCE) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Grace Therapeutics (GRCE) has outperformed Instil Bio (TIL) over the past year, losing 32.0% versus a loss of 68.0%. Over five years, GRCE leads with a -80.5% price change compared with -98.2% for TIL. Instil Bio is the larger company by market cap ($44.5 million vs $42.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GRCE | TIL |
|---|---|---|
| Share price | $2.04 | $6.56 |
| Market cap | $42.91M | $44.49M |
| 1-day change | -2.86% | -4.23% |
| YTD return | -41.04% | -40.36% |
| 1-year return | -32.00% | -68.05% |
| 5-year return | -80.46% | -98.17% |
| EPS (TTM) | $-1.17 | $-4.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.18 | $21.98 |
| 52-week low | $1.79 | $5.67 |
| Distance from 52-week high | -60.62% | -70.15% |
| Analyst consensus | none | none |
| Avg. price target upside | +187.75% | +6.71% |
| Average volume | 171.87K | 12.54K |
| Shares outstanding | 21.04M | 6.78M |
| Employees | 5 | 17 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GRCE has outperformed TIL by 36.0 percentage points over the past year.
About Grace Therapeutics
GRCE stock →Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
Healthcare · Biotechnology · 5 employees
About Instil Bio
TIL stock →Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Healthcare · Biotechnology · 17 employees
GRCE vs TIL FAQ
Which is bigger, Grace Therapeutics or Instil Bio?
Instil Bio (TIL) is larger, with a market capitalization of $44.49M compared with $42.91M for Grace Therapeutics (GRCE).
Which stock has performed better over the past year, GRCE or TIL?
GRCE returned -32.00% over the past 12 months, compared with -68.05% for TIL (price return, excluding dividends). Past performance does not predict future results.
Are Grace Therapeutics and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.